Skip to main content

Table 1 Patient characteristics at baseline

From: Effect of hyperinsulinemia during hemodialysis on the insulin-like growth factor system and inflammatory biomarkers: a randomized open-label crossover study

Variable n = 11
Age (years) 58 (33–79)
Sex (males/females) 8/3
Body mass index (kg/m2) 24.9 ± 3.6
Subjective global assessment score (A/B) 5/6
Hemodialysis vintage (months) 35 (11–232)
Dialysis days per week (2/3/4 days) 1/8/2
Urine production ≥ 200 mL/day (yes/no) 4/7
Kt/V 1.58 ± 0.38
Normalized nitrogen protein appearance rate (nPNA) (g/kg/day) 0.91 ± 0.16
Plasma albumin (g/L) 38.8 ± 2.1
pH 7.43 ± 0.03
S-HCO3- (mmol/L) 25.5 ± 2.0
Blood glucose (mmol/L) 5.2 ± 0.4
Serum insulin (pmol/L) 33.9 ± 19.1
Serum bioactive IGF-I (μg/L) 0.83 ± 0.27
Serum total IGF-I (μg/L) 124 ± 43
Serum IGFBP-1 (μg/L) 267 ± 147
Serum IGFBP-2 (μg/L) 1949 ± 1112
  1. Data are mean ± SD, median (range), or number.
  2. At baseline no differences were observed in biomarker concentrations between study days and overall mean concentrations are shown.